SE400472B - Forfarande for framstellning av en antihypertensiv komposition - Google Patents

Forfarande for framstellning av en antihypertensiv komposition

Info

Publication number
SE400472B
SE400472B SE7302895A SE7302895A SE400472B SE 400472 B SE400472 B SE 400472B SE 7302895 A SE7302895 A SE 7302895A SE 7302895 A SE7302895 A SE 7302895A SE 400472 B SE400472 B SE 400472B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
antihypertensive composition
antihypertensive
composition
Prior art date
Application number
SE7302895A
Other languages
English (en)
Inventor
C E Nelson
A Scriabine
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE400472B publication Critical patent/SE400472B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7302895A 1972-03-06 1973-03-01 Forfarande for framstellning av en antihypertensiv komposition SE400472B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (1)

Publication Number Publication Date
SE400472B true SE400472B (sv) 1978-04-03

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7302895A SE400472B (sv) 1972-03-06 1973-03-01 Forfarande for framstellning av en antihypertensiv komposition

Country Status (19)

Country Link
US (1) US3833727A (sv)
AT (1) AT331966B (sv)
BE (1) BE796288A (sv)
CA (1) CA1015662A (sv)
CY (1) CY951A (sv)
DD (1) DD103559A5 (sv)
FR (1) FR2181786B1 (sv)
GB (1) GB1385648A (sv)
HK (1) HK23378A (sv)
HU (1) HU165714B (sv)
IE (1) IE37326B1 (sv)
IL (1) IL41610A (sv)
KE (1) KE2839A (sv)
LU (1) LU67144A1 (sv)
MY (1) MY7800295A (sv)
NL (1) NL176746C (sv)
PH (1) PH18901A (sv)
SE (1) SE400472B (sv)
ZA (1) ZA731505B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
AT331966B (de) 1976-09-10
US3833727A (en) 1974-09-03
KE2839A (en) 1978-05-26
IL41610A (en) 1975-08-31
DE2310836B2 (de) 1976-11-04
CA1015662A (en) 1977-08-16
AU5266273A (en) 1974-08-29
FR2181786A1 (sv) 1973-12-07
BE796288A (fr) 1973-09-05
NL176746B (nl) 1985-01-02
IE37326L (en) 1973-09-06
GB1385648A (en) 1975-02-26
PH18901A (en) 1985-10-30
DD103559A5 (sv) 1974-02-05
IE37326B1 (en) 1977-06-22
ZA731505B (en) 1974-10-30
CY951A (en) 1978-12-22
IL41610A0 (en) 1973-04-30
HK23378A (en) 1978-05-12
HU165714B (sv) 1974-10-28
DE2310836A1 (de) 1973-09-20
NL7302728A (sv) 1973-09-10
FR2181786B1 (sv) 1976-05-14
NL176746C (nl) 1985-06-03
MY7800295A (en) 1978-12-31
ATA195873A (de) 1975-12-15
LU67144A1 (sv) 1973-09-06

Similar Documents

Publication Publication Date Title
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
SE382059B (sv) Forfarande for framstellning av nya substituerade piperidinderivat
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE417968B (sv) Forfarande for framstellning av penamderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE423540B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626B (fi) Anordning foer framstaellning av en behaollare
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE384510B (sv) Forfarande for framstellning av nya isoindolinpiperazinderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
SE400472B (sv) Forfarande for framstellning av en antihypertensiv komposition
DK135944C (da) Fremgangsmade til fremstilling af indolderivater
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror